PERTH, Australia – Drug and device companies in Australia may soon be able to bring their products to market more quickly via a new priority review designation.
PERTH, Australia – Following its IPO in August, Melbourne-based Adalta Pty Ltd. inked two deals this month, and is now moving to the clinic with its human version of the shark antibody platform, the i-body.
PERTH, Australia – Following its IPO in August, Melbourne-based Adalta Pty Ltd. inked two deals this month, and is now moving to the clinic with its human version of the shark antibody platform, the i-body.
PERTH, Australia – Although industry rated Australia's Therapeutics Goods Administration (TGA) high when it comes to performing its role ethically and with integrity, the agency has a ways to go when it comes to communicating with its stakeholders, a recent survey suggests.
PERTH, Australia – Although industry rated Australia's Therapeutic Goods Administration (TGA) high when it comes to performing its role ethically and with integrity, the agency has a ways to go when it comes to communicating with its stakeholders, a recent survey suggests.
MELBOURNE, Australia – With the global regenerative medicine market growing at 23 percent annually, Australia is well-positioned to play a significant role in that market, experts said during the AusBiotech conference.
MELBOURNE, Australia – Some big deals in the biopharma space in Australia over the last year have gotten the attention of big pharma, and the sector is keyed up over the courtship possibilities.
